| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |